Caleo Biotechnologies
Biotechnology Research • 
Washington, Washington, United States • 1-10 Employees
Company overview
| Headquarters | Washington, Washington, United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Caleo Biotechnologies
Samaneh Kamali
Co-Founder & Principle
About Caleo Biotechnologies
CaleoBio focuses on patient-first technologies to overcome the persistent limitations of conventional preclinical models. Our proprietary Organ-Dish platform is a self-organizing, multicellular system that replicates patient-specific tissue architecture and disease phenotypes relevant to multiple therapeutic areas. It supports mechanistic studies, drug screening, toxicology, and preclinical validation with greater human relevance. By combining biological complexity with computational imaging, we’re building a scalable framework to understand disease progression and therapeutic response. We’re actively seeking collaborators and partners to advance more predictive, human-relevant models.
Caleo Biotechnologies revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Caleo Biotechnologies has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Caleo Biotechnologies has never raised funding before.
Brazil
France
Czechia
Iran, Islamic Republic of
Frequently asked questions
4.8
40,000 users
